The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting nodal burden after neoadjuvant chemotherapy (NAC) with circulating tumor (ct)DNA for surgical planning: Results from the I-SPY2 trial.
 
Rita Mukhtar
Research Funding - GE Healthcare
Patents, Royalties, Other Intellectual Property - Patent on the use of fibrin and silver microparticles to promote wound healing. (I)
 
Katrina Dimitroff
No Relationships to Disclose
 
Christina Yau
Patents, Royalties, Other Intellectual Property - U.S. Provisional Application No. 63/314,065 (Inst); U.S. Provisional Application No. 63/341,579 (Inst); US Application No. 18/174,191 (Inst)
 
Laura van t Veer
Employment - Agendia
Stock and Other Ownership Interests - Agendia; Exai Bio
 
Jo Chien
Consulting or Advisory Role - Genentech/Roche
Research Funding - Amgen (Inst); Merck (Inst); Olema Oncology (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Pending Patent Application for “COMBINATION INCLUDING A CPG-C TYPE OLIGONUCLEOTIDE AND A PD-1 ANTAGONIST FOR TREATING BREAST CANCER”
Travel, Accommodations, Expenses - Genentech/Roche
 
Gillian Hirst
No Relationships to Disclose
 
Lamorna Brown Swigart
No Relationships to Disclose
 
Angela DeMichele
Consulting or Advisory Role - Pfizer (I)
Research Funding - Genentech (Inst); Inivata/NeoGenomics (Inst); Novartis (Inst); Pfizer (Inst)
 
Douglas Yee
Consulting or Advisory Role - Martell diagnostic
Research Funding - Fusion Pharmaceuticals
 
Hope Rugo
Honoraria - Chugai Pharma; Mylan/Viatris
Consulting or Advisory Role - Bristol Meyer; Napo Pharmaceuticals; Sanofi
Research Funding - Ambryx (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Hoffmann-La Roche AG/Genentech, Inc (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Stemline Therapeutics (Inst)
 
Rebecca Shatsky
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Endeavor BioMedicines; Guardant Health; Lilly; Novartis; Stemline Therapeutics; TEMPUS
Research Funding - AstraZeneca (Inst); Briacell (Inst); Gilead Sciences (Inst); Greenwich LifeSciences (Inst); OBI Pharma (Inst); OnKure (Inst); QuantumLeap Health (Inst); Regor Therapeutics (Inst); Stemline Therapeutics (Inst)
 
Claudine Isaacs
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech/Roche; Gilead Sciences; Merck; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier - Editor of Book; McGraw Hill Publishing; UpToDate - Wolters Kluwer - Author of chapters
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Curio/Vaniam Group; Medscape; MJH/PER; Side-Out Foundation
 
Kamran Ahmed
Honoraria - Bristol-Myers Squibb; Cancer Network; Castle Biosciences
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Lilly (Inst)
 
Julia Tchou
No Relationships to Disclose
 
Henry Kuerer
Consulting or Advisory Role - Merck; Targeted Medical Education, Inc.
Patents, Royalties, Other Intellectual Property - McGraw-Hill Publishing; NEJM Group
 
Chantal Reyna
No Relationships to Disclose
 
Candice Sauder
No Relationships to Disclose
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Moderna Therapeutics (Inst)
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative
 
Judy Boughey
Honoraria - UpToDate
Consulting or Advisory Role - CairnSurgical; SymBioSis (Inst)
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
Mark Jesus Magbanua
No Relationships to Disclose